KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹84 Cr | ₹64 Cr | ₹69 Cr | ₹69 Cr | ₹73 Cr |
What is the latest Total Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹84 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹73 Cr |
How is Total Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹84 Cr | 31.29 | |
| Mar2024 | ₹64 Cr | -6.76 | |
| Mar2023 | ₹69 Cr | -0.59 | |
| Mar2022 | ₹69 Cr | -5.51 | |
| Mar2021 | ₹73 Cr | - | |
Compare Total Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹472.2 Cr | 6.6% | -13.8% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,209.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,750.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,746.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,851.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,268.4 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 6.6% |
-13.8% |
-20% |
| SENSEX | 1.3% |
5.3% |
6.3% |
You may also like the below Video Courses